Dirk Jochmans

31PUBLICATIONS
214CO-AUTHORS
Biomolecular modelling and designCheminformatics and quantitative structure-activity relationshipsMedical virologyOrganometallic chemistryMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Oct 15, 2025
Identification and Exploration of a Series of SARS-Cov‑2 MPro Cyano-Based Inhibitors Revealing Ortho-Substitution Effects within the P3 Biphenyl Group.

Emma Clyde-Allen, Mikołaj Zmudzinski, Mohammad Afsar

|Jul 16, 2025
Open-science discovery of DNDI-6510, a compound that addresses genotoxic and metabolic liabilities of the COVID Moonshot SARS-CoV-2 Mpro lead inhibitor.

Ed J Griffen, Daren Fearon, Briana L McGovern

|Jun 30, 2025
Discovery and Preclinical Profile of ALG-097558, a Pan-Coronavirus 3CLpro Inhibitor.

Dorothée Bardiot, David C McGowan, Kusum Gupta

|Mar 27, 2025
A coronavirus assembly inhibitor that targets the viral membrane protein.

Manon Laporte, Dirk Jochmans, Dorothée Bardiot

|Mar 27, 2025
A small-molecule SARS-CoV-2 inhibitor targeting the membrane protein.

Ellen Van Damme, Pravien Abeywickrema, Yanting Yin

|Feb 26, 2025
The Combination of GS-441524 (Remdesivir) and Ribavirin Results in a Potent Antiviral Effect Against Human Parainfluenza Virus 3 Infection in Human Airway Epithelial Cell Cultures and in a Mouse Infection Model.

Yuxia Lin, Birgit Weynand, Xin Zhang

Pageof 6

Frequent Collaborators

21 joint publications

Johan Neyts

9 joint publications

Rana Abdelnabi

9 joint publications

Steven De Jonghe

8 joint publications

Birgit Weynand